STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.
Ontology highlight
ABSTRACT: Elucidating the contribution of somatic mutations to cancer is essential for personalized medicine. STK11 (LKB1) appears to be inactivated in human cancer. However, somatic missense mutations also occur, and the role/s of these alterations to this disease remain unknown. Here, we investigated the contribution of four missense LKB1 somatic mutations in tumor biology. Three out of the four mutants lost their tumor suppressor capabilities and showed deficient kinase activity. The remaining mutant retained the enzymatic activity of wild type LKB1, but induced increased cell motility. Mechanistically, LKB1 mutants resulted in differential gene expression of genes encoding vesicle trafficking regulating molecules, adhesion molecules and cytokines. The differentially regulated genes correlated wi
SUBMITTER: Granado-Martinez P
PROVIDER: S-EPMC7347935 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA